1980
DOI: 10.1016/0008-8749(80)90168-9
|View full text |Cite
|
Sign up to set email alerts
|

LPS-induced autoantibody response

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1981
1981
1992
1992

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 15 publications
(2 citation statements)
references
References 19 publications
0
2
0
Order By: Relevance
“…The involvement of external antigens, such as components of commensal bacteria, is unlikely since germfree and specific pathogen-free mice show comparable frequencies of anti-BrMRBC activity and VH11 gene family expression ( [50], Huetz et al, to be published). Concerning autoantigens, no evidence for an equivalent bromelain treatment of the RBC exist in vivo [51] and the soluble analogue of the epitope associated with low-density lipoprotein [52] is present in the mouse serum throughout development of the immune system; this does not fit with a delayed expression of anti-BrMRBC response assumed to take place [13, [53][54][55] if an autoantigen-driven selection operates.…”
Section: Discussionmentioning
confidence: 98%
“…The involvement of external antigens, such as components of commensal bacteria, is unlikely since germfree and specific pathogen-free mice show comparable frequencies of anti-BrMRBC activity and VH11 gene family expression ( [50], Huetz et al, to be published). Concerning autoantigens, no evidence for an equivalent bromelain treatment of the RBC exist in vivo [51] and the soluble analogue of the epitope associated with low-density lipoprotein [52] is present in the mouse serum throughout development of the immune system; this does not fit with a delayed expression of anti-BrMRBC response assumed to take place [13, [53][54][55] if an autoantigen-driven selection operates.…”
Section: Discussionmentioning
confidence: 98%
“…Naturally-occurring antibodies antigens than was previously possible, and this has to liposomal phospholipids and cholesterol are changed our views of lipids as antigens. The developwidespread in normal sera from animals and humans ment of liposomes as models for effector mechanisms [16,132,133,[148][149][150][151][152][153]. Remarkable similarities exist beof immune reactions [15,137], when combined with the tween the anti-liposome antibody model and the model discovery of the immunogenicity of liposomal phosphaemploying autoantibodies that react with bromelintidylcholine and other liposomal phospholipids treated erythrocytes, and this has led to the suggestion [16,132,138] and the production of monoclonal antibodthat the two models are different manifestations of the ies to liposomal cholesterol [139] (see Ref.…”
Section: Ili-c Antibodies To Bromelin-treated Erythrocytes: Amentioning
confidence: 99%